ADCYAP1 and digestive system disorder: An increase in the concentration of the DPP4 substrates GLP-1, GIP (also called Gastric Inhibitory Polypeptide), the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and oxyntomoduline has been related to gastrointestinal disorders [17,55].